Ph2 Open-label study of ZL-1310 in subjects with Neuroendocrine Carcinoma

Phase II Clinical Trial

A Phase Ib/II Open-label Multi-center Study of ZL-1310 in Participants with Selected Solid Tumors (ZL-1310-002)

Indication: Pancreatic Cancer, Pancreatic Cancer, Prostate Cancer, Prostate Cancer
Trial Number: 06885281
Trial Status: OPEN

Learn more about this clinical trial.

Participating Locations